These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2526239)

  • 1. Comparative evaluation of two once-a-month contraceptive injections.
    Kazi AI
    J Pak Med Assoc; 1989 Apr; 39(4):98-102. PubMed ID: 2526239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
    Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
    Contraception; 1985 May; 31(5):453-69. PubMed ID: 4028723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
    Contraception; 1988 Jan; 37(1):1-20. PubMed ID: 2896581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
    Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
    Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-a-month injectable contraceptives.
    d'Arcangues C
    World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
    Nooh AM; Abdeldayem HM; Girbash EF; Arafa EM; Atwa K; Abdel-Raouf SM
    Reprod Sci; 2016 Apr; 23(4):448-54. PubMed ID: 26718306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Contraception; 1998 Feb; 57(2):71-81. PubMed ID: 9589832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
    Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
    Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation.
    Contraception; 1989 Nov; 40(5):531-51. PubMed ID: 2692962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera.
    Hall PE
    Int J Gynaecol Obstet; 1998 Aug; 62 Suppl 1():S43-56. PubMed ID: 9806239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable and implantable contraceptives.
    Cullins VE
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
    Bortolotti de Mello Jacobucci MS; Guazzelli CA; Barbieri M; Araújo FF; Moron AF
    Contraception; 2006 Jun; 73(6):594-7. PubMed ID: 16730490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Garza-Flores J; Rodriguez V; Perez-Palacios G; Virutamasen P; Tang-Keow P; Konsayreepong R; Kovacs L; Koloszar S; Hall PE
    Contraception; 1987 Oct; 36(4):441-57. PubMed ID: 2964992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current options for injectable contraception in the United States.
    Kaunitz AM
    Semin Reprod Med; 2001 Dec; 19(4):331-7. PubMed ID: 11727175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg).
    Sierra-Ramírez JA; Lara-Ricalde R; Lujan M; Velázquez-Ramírez N; Godínez-Victoria M; Hernádez-Munguía IA; Padilla A; Garza-Flores J
    Contraception; 2011 Dec; 84(6):565-70. PubMed ID: 22078184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.